{"product_id":"generic-afatinib-luciafa","title":"LuciAfa (Afatinib)","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS AND USAGE\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eAfatinib is a kinase inhibitor indicated for:\u003c\/p\u003e\u003cp\u003e• First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations as detected by an FDA-approved test.\u003c\/p\u003e\u003cp\u003eLimitations of Use: Safety and efficacy of LuciAfa were not established in patients whose tumors have resistant EGFR mutations .\u003c\/p\u003e\u003cp\u003e• Treatment of patients with metastatic, squamous NSCLC progressing after platinum-based chemotherapy .\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eDOSAGE AND ADMINISTRATION\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003e• Recommended dosage: 40 mg orally once daily.\u003c\/p\u003e\u003cp\u003e• Renal impairment: 30 mg orally once daily in patients with severe renal impairment.\u003c\/p\u003e\u003cp\u003e• Instruct patients to take LuciAfa at least 1 hour before or 2 hours after a meal.\u003c\/p\u003e","brand":"Lucius Pharmaceuticals (Lao) Co., Ltd","offers":[{"title":"Default Title","offer_id":44797953998891,"sku":"RL3120250101","price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/2024-12-0834.jpg?v=1787022212","url":"https:\/\/xomeds.com\/products\/generic-afatinib-luciafa","provider":"XOMEDS","version":"1.0","type":"link"}